Plain-English translation of NCT07349524 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called RSS0343 to see if it can help people with COPD โ a serious lung disease that makes breathing difficult โ by reducing the number of severe flare-ups they experience. The study will compare the medication to a placebo (a dummy pill with no active ingredient) over 48 weeks to measure how well this treatment works and whether it is safe.
Many people with COPD experience frequent, serious flare-ups that get worse over time and require emergency care. This study exists to see whether this medication could help prevent those flare-ups and improve quality of life for people living with this condition.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have a 4-week screening period where doctors will confirm you qualify, then 48 weeks of treatment where you will take either the new medication or a placebo by mouth and visit the clinic for check-ups and breathing tests. After treatment ends, you will have a 4-week follow-up period to make sure everything is okay. Throughout the study, you will be monitored to see how many flare-ups you have and whether the medication is safe.
AI-generated summary from trial data ยท Jun 20, 2026 ยท Not medical advice
China